GSK PLC ORD 31 1/4P (GSK.L) Financials
GSK.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 5.9 trillion | 4.6 trillion |
| 2023-09-30 | 6.1 trillion | 4.8 trillion |
| 2023-06-30 | 5.9 trillion | 4.7 trillion |
| 2023-03-31 | 5.9 trillion | 4.7 trillion |
GSK.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 218.8 billion | -235.6 billion |
| 2023-09-30 | 171.5 billion | ? |
| 2023-06-30 | 77.2 billion | ? |
| 2023-03-31 | -47.6 billion | ? |
GSK.L Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 35.0 billion |
| 2023-09-30 | 153.4 billion |
| 2023-06-30 | 174.5 billion |
| 2023-03-31 | 163.1 billion |
GSK.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 518.2 billion | - | 120.7 billion |
| 2023-09-30 | 668.3 billion | - | - |
| 2023-06-30 | 650.4 billion | - | - |
| 2023-03-31 | 697.5 billion | - | - |
GSK.L Shares Outstanding
GSK.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 78.3 billion | 204.9 billion | 267.8 billion | -6.5 billion |
| 2023-09-30 | 49.7 billion | 157.5 billion | 229.6 billion | - |
| 2023-06-30 | 53.5 billion | 134.1 billion | 226.8 billion | - |
| 2023-03-31 | 52.9 billion | 126.0 billion | 214.3 billion | - |
GSK.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 805.2 billion | 233.8 billion |
| 2023-09-30 | 814.7 billion | 227.2 billion |
| 2023-06-30 | 717.8 billion | 193.2 billion |
| 2023-03-31 | 695.1 billion | 194.3 billion |
GSK.L
Price: £16.70
Dividend Yield: 0.00%
Forward Dividend Yield: 3.87%
Payout Ratio: 5333.33%
Dividend Per Share: 64.00 GBp
Earnings Per Share: 1.20 GBp
P/E Ratio: 13.68
Exchange: LSE
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 7.5 million
Market Capitalization: 65.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 32
DGR3: -9.27%
DGR5: -5.56%
DGR10: -4.17%
DGR20: 1.44%